AU2021104091A4 - Polyherbal capsule as a potential detoxification agent. - Google Patents
Polyherbal capsule as a potential detoxification agent. Download PDFInfo
- Publication number
- AU2021104091A4 AU2021104091A4 AU2021104091A AU2021104091A AU2021104091A4 AU 2021104091 A4 AU2021104091 A4 AU 2021104091A4 AU 2021104091 A AU2021104091 A AU 2021104091A AU 2021104091 A AU2021104091 A AU 2021104091A AU 2021104091 A4 AU2021104091 A4 AU 2021104091A4
- Authority
- AU
- Australia
- Prior art keywords
- polyherbal
- powder
- composition
- leaves
- plants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002775 capsule Substances 0.000 title claims description 8
- 238000001784 detoxification Methods 0.000 title abstract description 8
- 239000003795 chemical substances by application Substances 0.000 title description 4
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 241000196324 Embryophyta Species 0.000 claims abstract description 15
- 238000009472 formulation Methods 0.000 claims abstract description 14
- 235000008216 herbs Nutrition 0.000 claims abstract description 7
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 6
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 6
- 244000237986 Melia azadirachta Species 0.000 claims abstract description 6
- 235000013500 Melia azadirachta Nutrition 0.000 claims abstract description 6
- 244000136948 Ocimum sanctum Species 0.000 claims abstract description 6
- 235000004072 Ocimum sanctum Nutrition 0.000 claims abstract description 6
- 244000071109 Terminalia arjuna Species 0.000 claims abstract description 6
- 235000000538 Terminalia arjuna Nutrition 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 235000002901 Mentha sylvestris Nutrition 0.000 claims abstract description 5
- 244000182802 Mentha sylvestris Species 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 229940079832 sodium starch glycolate Drugs 0.000 claims description 2
- 239000008109 sodium starch glycolate Substances 0.000 claims description 2
- 229920003109 sodium starch glycolate Polymers 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 2
- 235000010234 sodium benzoate Nutrition 0.000 claims 2
- 229960003885 sodium benzoate Drugs 0.000 claims 2
- 239000004299 sodium benzoate Substances 0.000 claims 2
- 229940032147 starch Drugs 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 241000557821 Azadirachta Species 0.000 claims 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 231100000041 toxicology testing Toxicity 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 8
- 238000000746 purification Methods 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 5
- 231100000765 toxin Toxicity 0.000 abstract description 5
- 108700012359 toxins Proteins 0.000 abstract description 5
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000012674 herbal formulation Substances 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 abstract description 2
- 108010082126 Alanine transaminase Proteins 0.000 abstract 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 abstract 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 238000007705 chemical test Methods 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 1
- 238000010874 in vitro model Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 235000019629 palatability Nutrition 0.000 abstract 1
- 231100001271 preclinical toxicology Toxicity 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 235000017807 phytochemicals Nutrition 0.000 description 4
- 229930000223 plant secondary metabolite Natural products 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000058084 Aegle marmelos Species 0.000 description 1
- 235000003930 Aegle marmelos Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005474 detonation Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000007434 physicochemical evaluation Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 231100000064 subacute toxicity study Toxicity 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
In one aspect of the present disclosure, a herbal formulation is developed which includes leaves
of ocimum sanctum, bilwapatra, leaves of Mentha longifolia, bark of terminalia arjuna, fruits of
Phyllanthus emblica, leaves of Azadirachta indica in a unique proportion, this herbal synergistic
detoxifier composition is effective for blood purification, detoxification , All the herbs which
have history of clinical use as single or in other combinations, but these plant fractions were
never tried collectively in this ratio as in our formulation, which has been found to be effective
on all the etiological factors, together and in the treatment and management of disorders related
to accumulation of toxins in the body.In the present invention, the formulation developed has
synergistic herbal composition has better patient compliance in the terms of palatability, ease of
administration and effectiveness.
Although, Indian system of medicine, especially Ayurveda has several medicinal plants with
proven beneficial claims towards these pathological conditions, but most of them lack enough
experimental data. In this invention, antioxidant, enzyme ratio(SGOT,SGPT) hypo-lipidemic,
anti-proliferative properties of this formulation have been studied on several experimental
models based on chemical tests, cell culture, in vitro models, and in vivo experiments with
normal and transgenic animals. A separate pre-clinical toxicity study has also been carried out to
prove its safety margin in therapeutic doses.
Description
Title of Invention
Polyherbal capsule as a potential detoxification agent.
The present disclosure relates to a polyherbal capsule, which is having potential to work as detoxification agent.
Background
Although, Indian system of medicine, especially Ayurveda has several medicinal plants with proven beneficial claims towards these pathological conditions, but most of them lack enough experimental data. Blood purification practices, additionallyknown as blood cleaning or detoxification, is an historicalideathis isvastamong Indians conventional medicine, however for which no present daymedicalfoundation exists. The perception of the starting place of ailment as an imbalance of regular functioning, be it physiological, mental or spiritual; humour, or essentiallife force energy , is deeply embedded in maximum nonwestern understandings of ailment. Related to that is the ideathat after the imbalances worsen, so does the severity of signs. For example, moderate imbalances may alsogift as acne, whileexcessive disequilibrium is lifestyles threatening. The exercise of blood purification consequentlygives the possibility to rebalance the perceived discord in physiological function, whether or notvia way of means oflife style or natural intervention, or both, to save you the developmentalongside the spectrum of signs to terminal ailment. Ranging from the skin to liver, body has an in-built detox system that keeps it running smoothly on a daily basis. Due to the present life-style, increased stress, pollution, unhealthy dietary habits, the natural system gets weakened. The need of present time is to unveil the herbs present in the nature full of detox potential, inheriting the capacity to purify the kidney, liver, gut, skin and blood. These herbal detoxifiers facilitate lungs, aids kidneys, facilitates digestive tract and skin. The present innovation deals with the six herbs under the category of detoxifiers for kidney, liver, gut, skin and blood .
Summary of Invention
The present invention provides a non parenteral herbal synergistic detoxifier composition effective for blood purification, blood detoxification and in the treatment and management of disorders related to accumulation of toxins in the body. The present invention also provided a method of preparation of this formulation. In a preferred embodiment, the composition comprises leaves of ocimum sanctum,bilwapatra,leaves of Mentha longifolia, bark of terminalia arjuna,fruits of Phyllanthus emblica,leaves of Azadirachtaindica. In particular, the present invention provides a polyherbal powder of extracts without using any excipients and preservatives and process for preparing the same.
The goal of the discovery is to offer novel synergistic polyherbal detoxifier composition for blood purification, entire blood detoxification. Another item of the discovery is to applyminimalwide variety of livelycomponents in a synergistic way and to apply least quantity of administrable drug for acquiringhealingimpact of detoxification. Still any otheritem of the discovery is to growth the bio availability of the livelycomponents. Another goal of the existing invention is to revealnatural formulations with novel system. Another things is to reveal compositions and techniqueof producing of the stated formulations. Yet another object of the invention is to provide patient compliance matching habit and lifestyle thereby providing ease of administration without much burden on patient to remember schedule of taking medicine.
The herb used are rich in many antioxidants like polyphenols that reduce oxidative stress. It contains the perfect blend of nutrients like vitamin A and other essential minerals. The herbal extracts can detoxify your body, promote digestive abilities, and cleanse the system. With the right supplements, one can remove the metallic toxins in blood and boost the metabolism.
The embodiments herein and the various features and advantageous details thereof are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein. Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. As used herein, the singular forms "a", "an", "the" include plural referents unless the context clearly dictates otherwise. Further, the terms "like", "as such", "for example", "including" are meant to introduce examples which further clarify more general subject matter, and should be contemplated for the persons skilled in the art to understand the subject matter. Although this invention has been described in conjunction with the exemplary embodiments' below, it is evident that many alternatives, modifications, and variations will be apparent to those skilled in the art. Accordingly, the exemplary embodiments of the invention as set forth above are intended to be illustrative and not limiting. Various changes may be made without departing from the spirit and scope of the invention.
This cost effective polyherbal detoxifier agent is ideal for use as detox for the major organs of the body not only helps to remove the toxins but also increases the overall energy and efficiency of the body. This formulation promises to promote weight loss and liver health, kidney, cardiac, improve blood sugar levels, and remove toxins from the body.
Polyherbal Powder is used instead of synthetic so as minimize the side effects and increase the potency of the treatment.
Bael leaves are a power punch of various nutrients like beta-carotene, protein, riboflavin and vitamin C. It is loaded with vitamin B and B2, thiamine, riboflavin, niacin, carotene and possesses good amounts of minerals like calcium, potassium, fiber and good fats.
These fruits are also popular for antioxidant, anti-inflammatory properties and it has been in use for its medicinal and therapeutic properties in Ayurveda, Siddha and other forms of alternate medicine for thousands of years.
Same as neem, it's extremely powerful at detoxing important internal organs. So, use it to cleanse your liver and stimulate your kidneys. It also detoxes the blood from germs picked up on a day to day basis.
The formulation selected is in the form of capsules because it offers unique mixes of ingredients possible, faster absorption, better and release kinetics as compared to tablets.
The polyherbal powder was prepared by mixing the selected 6 herbs in a particular ratio. The ratio selected for the preparation of PHP was in the ratio of 1:2:1:1:1:2 which includes herbs in the order tulsi,bilwa,mint,arjun, amla &neem respectively.
The selected herbs were first properly washed, and shade dried and then they were blend into a fine powder using mixer grinder. The obtained polyherbal powder was then made to get fine and homogenous particles by using sieve of sieve 60 mesh size. Then further evaluation tests were performed for the poly herbal powder.
Following steps
i. Identification and authentication of collected plant material. ii. Extraction of plant using maceration process. iii. Standardization of plant extract. - Physical examination - Phytochemical screening - Rheological study iv. Spectral Analysis - IR Spectroscopy v. Determination of toxicity through: - Acute oral toxicity study (14 days) - Subacute oral toxicity study (28 days) vi. The polyherbal powder was evaluated for organoleptic evaluation, physicochemical evaluation including moisture content, total ash, water soluble ash, water insoluble ash and extractive values. The moisture content was found to stable around 6±0.1%-7±0.1% as more the moisture content; more will the chances of detonation of the formulation. vii. The calculated values of ash value 8±0.1% -9±0.1% also showed less sign of any adulteration. The extractive value, showed more in case of ethanol than in water. Therefore, for the extraction of the polyherbal powder, ethanol medium was used; which showed better extraction. The rheological properties were also evaluated for the polyherbal powder, which showed excellent flow properties of the powder in case of angle of repose and Hausner's ratio, the Carr's index showed good flow property. The particle size was also evaluated, which showed that the particles passed from sieve 10, 22, 60, and 120. The cumulative % mass retained on sieve number 120 was found to be the maximum. Hence, the particle size was appropriate for the preparation of the formulation. The fluorescence test was also positive. viii. The extract was prepared ethanol solvent. The extract was evaluated for the phytochemical properties; it showed positive result for most of the tests which shows the extract had all the phytochemical properties. The chromatographic analysis was done in ethyl acetate: n-hexane mobile phase.(8:2) The TLC plate showed separation of various phytoconstituents when observed under the UV chamber. The pH study showed that drug was soluble in slightly alkaline medium. Therefore, pH 6.8 phosphate buffer was used for the solubility analysis and showed maximum absorption in the solubility test. The partition coefficient analysis showed drug was more soluble in aqueous phase. ix. The granules were then evaluated for the flow properties, in which F6 showed the best flow properties and all the prepared granules of different ratios showed excellent and good flow properties. The moisture content was also as per the standards. The granules showed faster disintegration with addition of sodium starch glycolate, as the concentration of super disintegrant and increased, the disintegration also increased. Thus, formulation when taken with water will disintegrate at a faster rate when compared with other formulations.
Comparative assessment
Marketed preparation of Detox Plus herbal tablet is similar to our product in terms of therapeutic effects, which we found during our comparative study.
The basic difference in between the marketed preparation and our herbal formulation is as:
- Polyherbal capsules is used instead of powder or tablet so as minimise the side effects and increase the potency of the treatment. - Our formulation is based on capsules dosages form and is easy to extract and cost effective. - The prepared capsules are fast disintegrating. They showed no signs of toxicity when
acute and sub acute toxicity studies were performed. The benefits related to our product is as:
The capsule formulation provides taste masking; it offers unique mixes of ingredients possible, protection for sensitive ingredients, faster absorption as compared to tablets. It also provides faster disintegration and better release kinetics.
The problems which can be solved by our idea is as:
- It can counter the side effects produced by synthetic marketed preparation. - It can be cost effective. - It can increase patient compliance
Claims (8)
1. The formulation comprises leaves of ocimum sanctum, bilwapatra, leaves of Mentha longifolia, bark of terminalia arjuna, fruits of Phyllanthus emblica,leaves of Azadirachta indica in a unique proportion.
2. Extraction of raw materials is carried out by mixing the extracting material and 70% ethanol at a ratio of 2:10 and placing it in a 5 L round bottom flask equipped with a reflux condenser and extracting three times for 8 hours at 75 to 80 ° C. with a mantle heater to reduce the temperature to 50 ° C. Concentrated in rotatary evaporator.
3. The composition of claim 1 is prepared by mixing lactose, starch, sodiumSSG,Sodiumbenzoate,MCC,Magnesiumstaerate
4. The composition of claim 1 is prepared by mixing the selected 6 herbs in a particular ratio.
5. The composition of claim 1 wherein the components of the composition from Ocimum sanctum & Mentha Longifolia are present in ratio in between 10-15 % 6. The composition of claim 1 wherein the components of the composition from Bilwa Patra
& extract from leaves of azadirachta are present in ratio in between 20-30 %
7. The composition of claim 1 wherein the components of the composition from bark of terminalia arjuna & fruits of Phyllanthus emblica are present in ratio in between 10-15 %
8. A process for preparation of the polyherbal composition as claimed in claim 1, the process comprising: (i) washing and drying plants to obtain dried plants; (ii) powdering and optionally sieving the dried plants obtained in step (i) to obtain fine powders of each of the dried plants; (iii) blending the fine powders of each of the dried plants obtained in step (ii) to obtain a blend of plants; and (iv) extracting the blend of plants of step (iii) using a solvent to obtain an extract of a blend of plants and concentrating the extract of the blend of plants and optionally adding excipients to obtain the polyherbal composition; wherein the plants are selected from the group consisting of leaves of ocimum sanctum, bilwapatra, Mentha longifolia, bark of terminalia arjuna, fruits of Phyllanthus emblica, leaves of Azadirachta indica.
Prepared granules Hand operated capsule filling machine
Prepared herbal capsulesDosing while toxicity study
Organoleptic Property Result Color seen Dark Brown Odour sensed Very Characteristic Taste evaluation Astringent Appearance of the powder Fine blend of poly herbal powder
Organoleptic properties of the powder blend
The mixture of polyherbal powder and excipients and observed changes in 4 weeks
S.No. Samples Week 1 2 3 4 1 Polyherbal powder (100mg) No change
2 Polyherbal powder+ Lactose No change
3 Polyherbal powder+ Starch No change
4 Polyherbal powder+ Talc No change
5 Polyherbal powder+ Magnesium stearate No change
6 Polyherbal powder+ Sodium benzoate No change
7 Polyherbal powder+ Microcrystalline cellulose No change
8 Polyherbal powder+ Sodium starch glycolate No change
The sample contains 100 mg Polyherbal powder+ 100 mg excipients
FT-IR of Polyherbal Powder
.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021104091A AU2021104091A4 (en) | 2021-07-13 | 2021-07-13 | Polyherbal capsule as a potential detoxification agent. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021104091A AU2021104091A4 (en) | 2021-07-13 | 2021-07-13 | Polyherbal capsule as a potential detoxification agent. |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021104091A4 true AU2021104091A4 (en) | 2021-09-09 |
Family
ID=77563841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021104091A Ceased AU2021104091A4 (en) | 2021-07-13 | 2021-07-13 | Polyherbal capsule as a potential detoxification agent. |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021104091A4 (en) |
-
2021
- 2021-07-13 AU AU2021104091A patent/AU2021104091A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ekka et al. | Ethno-pharmacognostical studies of medicinal plants of Jashpur district (Chhattisgarh) | |
CN105475543A (en) | Black tea composition for eliminating oral diseases like ozostomia and preparation method thereof | |
KR20190132420A (en) | Herbal composition | |
CN110882309A (en) | Traditional Chinese medicine composition for treating chicken synovial capsule mycoplasma disease and preparation method thereof | |
CN101172145A (en) | Medicament for clearing heat, eliminating phlegm, relieving cough smoothing lung and preparation method thereof | |
AU2021104091A4 (en) | Polyherbal capsule as a potential detoxification agent. | |
KR101987554B1 (en) | Method of the sprout barley mixture tea increased content of antioxidant or active ingredient of Anti-diabetic with eliminating the unpleasant odor of sprout barley, powder of silkworm and leaves of Cudrania tricuspidata | |
KR100923043B1 (en) | Blood pressure therapeutic agent for chinese medicine and manufacture method thereof | |
KR100847440B1 (en) | Drug of herbal mixture for treating or preventing inflammatory diseases | |
CN104918627B (en) | Pharmaceutical composition having preventive or therapeutic effect on inflammatory bowel disease | |
KR20040101598A (en) | Active fraction having weight loss effects on Leprdb/Leprdb mice isolated from medicinal plants | |
Alam et al. | Therapeutic use of Withania somnifera | |
KR20020078467A (en) | Drink for tonic liver and Manufacture process the same. | |
KR101028073B1 (en) | Natural herb medicine composition improving blood circulation and immune activity of human body and its process of production | |
CN101229317B (en) | Medicine for removing heat-phlegm, relieving cough, and moistening lung and preparing method thereof | |
KR101934810B1 (en) | Preparation for improving blood circulation comprising oriental medicinal extracts | |
CN104435072B (en) | A kind of extract and preparation method thereof with auxiliary hyperglycemic, reducing blood lipid | |
CN108567878B (en) | Traditional Chinese medicine composition for preventing and treating fungal dermatopathy | |
KR101167628B1 (en) | A composition comprising black ginseng for treating or preventing dementia and improving cognitive function | |
RU2257221C1 (en) | Helminthicide species | |
CN114533835B (en) | A Chinese medicinal composition with effects of removing pathogenic wind and dampness, and its preparation method | |
Naman et al. | Anti-Anaemic Potential of Methanolic Leaf Extract of Mucuna Pruriens on Phenylhydrazine (Phz) Induced Anaemic Albino Wistar Rats | |
CN100522236C (en) | Medicinal capsule for treating gastrointestinal disease and preparation method thereof | |
KR101934811B1 (en) | Preparation for improving blood circulation comprising mixed medicinal extracts | |
CN102451274A (en) | Leatherleaf-mahonia-containing Chinese medicinal preparation for reducing internal heat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |